table2.svg (49.77 kB)
TABLE 2. Antipseudomonal antibiotics received by patients associated with the P-strains (n=124) from the study panel, before and after the identification of P. aeruginosa during the stay.
Version 2 2022-11-10, 19:16
Version 1 2022-11-10, 17:28
figure
posted on 2022-11-10, 19:16 authored by Marine PottierMarine Pottier, François Gravey, Sophie Castagnet, Michel Auzou, Bénédicte Langlois, François Guérin, Jean-Christophe Giard, Albertine Léon, Simon Le HelloNo more description
Funding
Normandy Regional Council (France)
French Ministry of Agriculture (EcoAntibio Plan)
History
Usage metrics
Categories
Keywords
didecyldimethylammonium chloride (DDAC)antibioresistanceantibiotichospital environmenthospitalclinicalHospital environmental contaminationPseudomonas aeruginosaVIM-2carbapenemaseGES-5resistomesinkPseudomonascarbapenemsantimicrobial resistance geneserotypingtypingMLSTMultilocus Sequence TypingCore genomeCore genome MLSTcgMLSTdiversityhigh-risk clonesMicrobiologyClinical MicrobiologyMedical Microbiology not elsewhere classified
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC